Factors affecting physicians' responses to patients' requests for antidepressants: focus group study
- PMID: 17987348
- PMCID: PMC2173928
- DOI: 10.1007/s11606-007-0441-8
Factors affecting physicians' responses to patients' requests for antidepressants: focus group study
Abstract
Background: The ways in which patients' requests for antidepressants affect physicians' prescribing behavior are poorly understood.
Objective: To describe physicians' affective and cognitive responses to standardized patients' (SPs) requests for antidepressants, as well as the attitudinal and contextual factors influencing prescribing behavior.
Design: Focus group interviews and brief demographic questionnaires.
Participants: Twenty-two primary care physicians in 6 focus groups; all had participated in a prior RCT of the influence of patients' requests on physicians' prescribing.
Measurements: Iterative review of interview transcripts, involving qualitative coding and thematic analysis.
Results: Physicians participating in the focus groups were frequently unaware of and denied the degree to which their thinking was biased by patient requests, but were able to recognize such biases after facilitated reflection. Common affective responses included annoyance and empathy. Common cognitive reactions resulted in further diagnostic inquiry or in acquiescing to the patient's demands to save time or build the patient-clinician relationship. Patients' requests for medication prompted the participants to err on the side of overtreating versus careful review of clinical indications. Lack of time and participants' attitudes--toward the role of the patient and the pharmaceutical ads--also influenced their responses, prompting them to interpret patient requests as diagnostic clues or opportunities for efficiency.
Conclusions: This study provides a taxonomy of affective and cognitive responses to patients' requests for medications and the underlying attitudes and contextual factors influencing them. Improved capacity for moment-to-moment self-awareness during clinical reasoning processes may increase the appropriateness of prescribing.
Figures
Similar articles
-
Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial.JAMA. 2005 Apr 27;293(16):1995-2002. doi: 10.1001/jama.293.16.1995. JAMA. 2005. PMID: 15855433 Free PMC article. Clinical Trial.
-
Do patient requests for antidepressants enhance or hinder physicians' evaluation of depression? A randomized controlled trial.Med Care. 2006 Dec;44(12):1107-13. doi: 10.1097/01.mlr.0000237202.96962.fd. Med Care. 2006. PMID: 17122715 Clinical Trial.
-
How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA.CMAJ. 2003 Sep 2;169(5):405-12. CMAJ. 2003. PMID: 12952801 Free PMC article.
-
Effects of Direct-To-Consumer Advertising on Patient Prescription Requests and Physician Prescribing: A Systematic Review of Psychiatry-Relevant Studies.J Clin Psychiatry. 2016 Oct;77(10):e1293-e1300. doi: 10.4088/JCP.15r10325. J Clin Psychiatry. 2016. PMID: 27631149 Free PMC article. Review.
-
Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.BMJ Open. 2017 Sep 27;7(9):e016408. doi: 10.1136/bmjopen-2017-016408. BMJ Open. 2017. PMID: 28963287 Free PMC article. Review.
Cited by
-
Primary care physician responses to requests by older adults for unnecessary drugs: a qualitative study.BMC Prim Care. 2022 Sep 26;23(1):247. doi: 10.1186/s12875-022-01857-x. BMC Prim Care. 2022. PMID: 36154834 Free PMC article.
-
Direct-to-Consumer Advertising of Prescription Drugs and the Patient-Prescriber Encounter: A Systematic Review.Health Commun. 2020 May;35(6):739-746. doi: 10.1080/10410236.2019.1584781. Epub 2019 Apr 11. Health Commun. 2020. PMID: 30973021 Free PMC article.
-
Do coverage mandates affect direct-to-consumer advertising for pharmaceuticals? Evidence from parity laws.Int J Health Econ Manag. 2018 Sep;18(3):321-336. doi: 10.1007/s10754-018-9234-3. Epub 2018 Jan 29. Int J Health Econ Manag. 2018. PMID: 29380108
-
The role of emotion in clinical decision making: an integrative literature review.BMC Med Educ. 2017 Dec 15;17(1):255. doi: 10.1186/s12909-017-1089-7. BMC Med Educ. 2017. PMID: 29246213 Free PMC article. Review.
-
"Psychiatry is not a science like others" - a focus group study on psychotropic prescribing in primary care.BMC Fam Pract. 2013 Aug 12;14:115. doi: 10.1186/1471-2296-14-115. BMC Fam Pract. 2013. PMID: 23937398 Free PMC article.
References
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1001/jama.293.16.2030', 'is_inner': False, 'url': 'https://doi.org/10.1001/jama.293.16.2030'}, {'type': 'PubMed', 'value': '15855439', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15855439/'}]}
- Hollon M. Direct to consumer advertising: a haphazard approach to health promotion. JAMA. 2005;293:2030–3. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1001/jama.281.4.380', 'is_inner': False, 'url': 'https://doi.org/10.1001/jama.281.4.380'}, {'type': 'PubMed', 'value': '9929095', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9929095/'}]}
- Holmer AF. Direct-to-consumer prescription drug advertising builds bridges between patient and physicians. JAMA. 1999;281:380–2. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '9420585', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9420585/'}]}
- Lipsky MS, Taylor CA. The opinions and experiences of family physicians regarding direct-to-consumer advertising. J Fam Pract. 1997;45:495–9. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '11813459', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11813459/'}]}
- Young D. Studies show drug ads influence prescription decisions, drug costs. Am J Health Syst Pharm. 2002;59:14, 16. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1371/journal.pmed.0030145', 'is_inner': False, 'url': 'https://doi.org/10.1371/journal.pmed.0030145'}, {'type': 'PMC', 'value': 'PMC1420390', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC1420390/'}, {'type': 'PubMed', 'value': '16563041', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16563041/'}]}
- Almasi EA, Stafford RS, Kravitz RL, Mansfield PR. What are the public health effects of direct-to-consumer drug advertising? PLoS Med. 2006;3:e145. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
